Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1666 AL 1680

Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study

Roede JR, Uppal K, Park Y, Lee K, Tran V, Walker D, Strobel FH, Rhodes SL, Ritz B, Jones DP.

PLoS One. 2013 Oct 22;8(10):e77629. doi: 10.1371/journal.pone.0077629. eCollection 2013.

Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review

Poletti M, Bonuccelli U.

Ther Adv Psychopharmacol. 2013 Apr;3(2):101-13. doi: 10.1177/2045125312470130.

[Homocysteine and its role in pathogenesis of Parkinson's disease and other neurodegenerative disorders]

Szadejko K, Szabat K, Ludwichowska A, Sławek J.

Przegl Lek. 2013;70(7):443-7.

[Efficacy and safety of ropinirole in the treatment of Parkinson's disease: a multi-center, randomized, double-blind and bromocriptine-controlled trial]

Li SH, Chen HB, Wang ZF, Tang RH, Zhang XY, Yang JS, Zhao WQ, Sun XR, Ma J.

Zhonghua Yi Xue Za Zhi. 2013 Jul 2;93(25):1952-7.

REM sleep behavior disorder in Parkinson's disease: A case from India confirmed with polysomnographic data

Gupta R, Goel D, Walker J, Farney RJ.

J Neurosci Rural Pract. 2013 Aug;4(Suppl 1):S91-4. doi: 10.4103/0976-3147.116422.

Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments

Bargiotas P, Konitsiotis S.

Neuropsychiatr Dis Treat. 2013;9:1605-17. doi: 10.2147/NDT.S36693. Epub 2013 Oct 22.

Molecular imaging as a guide for the treatment of central nervous system disorders

Kim E, Howes OD, Kapur S.

Dialogues Clin Neurosci. 2013 Sep;15(3):315-28. doi: 10.31887/DCNS.2013.15.3/ekim.

Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease

Gregório ML, Pinhel MA, Sado CL, Longo GS, Oliveira FN, Amorim GS, Nakazone MA, Florim GM, Mazeti CM, Martins DP, Tognola WA, Brandão AC, Júnior SP, de Godoy MF, Souza DR.

Biomed Res Int. 2013;2013:641515. doi: 10.1155/2013/641515. Epub 2013 Sep 24.

Low Voltage Electric Injury induced Atrial Fibrillation as a Presenting Feature of Wolff-Parkinson-White Syndrome: A Case Report

Hafeez I, Sohail MM, Lone A, Gupta A, Iqbal K, Aslam K, Alai MS, Iqbal S.

Oman Med J. 2013 Nov;28(6):e061. doi: 10.5001/omj.2013.130.

Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions

Ferraris D, Yang Z, Welsbie D.

Future Med Chem. 2013 Oct;5(16):1923-34. doi: 10.4155/fmc.13.150.

The added value of semimicroelectrode recording in deep brain stimulation of the subthalamic nucleus for Parkinson disease

Jonker PK, van Dijk JM, van Hulzen AL, van Laar T, Staal MJ, Journée HL.

Neurosurg Focus. 2013 Nov;35(5):E3. doi: 10.3171/2013.8.FOCUS13289.

Pallidotomy after chronic deep brain stimulation

Bulluss KJ, Pereira EA, Joint C, Aziz TZ.

Neurosurg Focus. 2013 Nov;35(5):E5. doi: 10.3171/2013.8.FOCUS13293.

Deep brain stimulation (DBS) at the interface of neurology and psychiatry

Williams NR, Okun MS.

J Clin Invest. 2013 Nov;123(11):4546-56. doi: 10.1172/JCI68341. Epub 2013 Nov 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias